Creative Edge Nutrition Inc (FITX)

[ORCA]

EXAMPLE OF F/S.MDVN.CHECK BOLD.PRICE MOVEMENT.ROCKED.AND ROCKED even more after the split.Look dates below.And price movements.
Capital Change=shs increased by 2 for 1 split. Ex-date=09/24/2012. Rec date=09/07/2012. Pay date=09/21/2012.

2012/10/08 58.02 58.08 55.81 56.18 657,675 56.18
First Prev Next Last


2012/09/04 106.10 113.00 106.10 109.21 1,875,950 109.21
2012/08/31 97.79 105.00 97.38 104.93 1,106,337 104.93
2012/08/30 97.86 98.62 97.30 97.42 234,722 97.42
2012/08/29 96.58 98.08 95.97 98.02 318,362 98.02
2012/08/28 96.40 97.00 95.40 96.17 152,133 96.17

Aug 28, 2012, 2:39pm PDT UPDATED: Aug 28, 2012, 4:51pm PDT
Stocks
Medivation to take 2-for-1 split of soaring stock Sept. 21



Ron Leuty
Reporter-
San Francisco Business Times
Email | Biotech tweets | Google+ | Education tweets
Medivation Inc., whose shares have soared more than 500 percent since early November, will take a 2-for-1 forward split of its common stock.
Due to the promise of its late-stage experimental prostate cancer drug enzalutamide, the San Francisco-based drug developer (NASDAQ: MDVN) has seen its stock rise to a 52-week high of $103.89, from $16.10 per share less than 10 months ago.
The stock closed Tuesday at $96.17 per share, but had added another 52 cents in after-hours trading.
Enzalutamide is scheduled to be approved by the Food and Drug Administration by Nov. 22.
The company, led by CEO David Hung, said the split would take effect Sept. 21 for stockholders of record on Sept. 7.
Each share of common stock, including shares subject to options and shares available for grant under the company's equity incentive plans, will automatically split into two shares.